Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

A 55-year-old man was diagnosed with autosomal dominant polycystic kidney disease (ADPKD) at the Medicover Hospital in Navi Mumbai, caused by a genetic fault that disrupts the normal development of ...

But until recently, we haven’t had any therapeutics to target the root cause of geographic atrophy, an advanced form of dry AMD. Pegcetacoplan (Syfovre) is the first FDA-approved drug to slow ...

Geographic atrophy (GA) can be visually confusing. People often tell me that one minute they see something, and the next minute they don’t. For example, the word you’re reading might be “she ...

Participants with weaker kidney function had a lower cognitive performance, regardless of age, sex, education, body mass index or cardio-vascular health. They also demonstrated brain atrophy ...

Our goal is to confirm the safety of our drug candidate to then rapidly move into a Phase II proof-of-concept study, to demonstrate transferrin’s ability to protect retinal cells from atrophy and ...

In a new study from the centre published in Nature Communications, the researchers examined brain atrophy and memory in healthy individuals aged 30 to 89 years. They found increased brain atrophy – ...

Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient ...

Chronic kidney disease (CKD) is an umbrella term used to describe a longstanding disease or condition that causes the progressive loss of kidney (renal) function. Symptoms vary, depending on the stage ...

Credit: Diana Shechtman, OD Sherrol A. Reynolds, OD, FAAO, FNAP, identifies patients who are most at risk for geographic atrophy and provides clinicians with guidance for managing the ...

The drug has already demonstrated efficacy at slowing the growth of lesions in patients with geographic atrophy in a phase 2 trial, the company said. In a statement, David Guyer, M.D., board chair ...